<p>Grip strength measurements of C57 SOD1G93A (A) and 129Sv SOD1G93A (B) mice analysed in vivo for T2 relaxation time. Time points of MRI and histological studies are reported as arrows in correspondence to the respective ages of analysis: ON = Onset, SS = symptomatic, AS = advanced stage. (C) Disease onset of C57 SOD1G93A (15.6 ± 0.8) and 129Sv SOD1G93A mice (13.8 ± 0.4) analysed with T2 MRI. Statistical analysis: Student’s t-test. ** = p-value<0.01. Data are expressed as mean ± SD. N = 6 animals for C57 SOD1G93A mice and 5 animals for 129Sv SOD1G93A mice.</p
<p>(A) Control and MB-treated (3, 10, 30 and 100 mg oral per kg body weight per day) SOD1<sup>G93A</...
Graphs displaying the average longitudinal values of the mdx4cv and control mice muscles in the T2, ...
<p>Group average change from initial body weight (top panels) and neurological disease severity scor...
<p>(A) Motor signs (hind limb tremors) were measured with the clinical scoring system (see methods)....
<p>(A) Representative T2-weighted images are shown from a SOD1G93A (G93A) and a non-transgenic (Ntg)...
<p>(A-B) Grip strength as latency to fall (sec) and body weights (g) in Ntg and SOD1<sup>G93A</sup> ...
<p>Given are parameters for disease onset (A-C), and survival (D) for the SOD-1 (G93A) (n = 17) and ...
<p>(<b>A</b>) Time elapsed until animals lost 15% of their maximum body weight. Mice receiving 1×10<...
<p>A) body weight, B) extension reflex, and C) rotorod test of G93A mice administered with three dif...
<p>(A) IMM was evaluated in Ntg and longitudinally in SOD1<sup>G93A</sup> mice at 12, 14, 17 and 20 ...
<p>(A) Grip strength measurements for the WT (blue) and VCP<sup><b>R155H/+</b></sup> (red) mice plac...
<p>(A) Lateral view of hindlimbs from WT and NF90 Tg mice (line TG1) at 12 weeks of age. An arrow in...
<p><b>A.</b> Myotonia was measured and scored on a 3 point scale with 0 being no myotonia and 3 bein...
<p>Histograms from Kaplan-Meier analysis showing the duration of the early phase (A) and the end sta...
As a model for amyotrophic lateral sclerosis (ALS), transgenic hSOD1(G93A) mice constitute the stand...
<p>(A) Control and MB-treated (3, 10, 30 and 100 mg oral per kg body weight per day) SOD1<sup>G93A</...
Graphs displaying the average longitudinal values of the mdx4cv and control mice muscles in the T2, ...
<p>Group average change from initial body weight (top panels) and neurological disease severity scor...
<p>(A) Motor signs (hind limb tremors) were measured with the clinical scoring system (see methods)....
<p>(A) Representative T2-weighted images are shown from a SOD1G93A (G93A) and a non-transgenic (Ntg)...
<p>(A-B) Grip strength as latency to fall (sec) and body weights (g) in Ntg and SOD1<sup>G93A</sup> ...
<p>Given are parameters for disease onset (A-C), and survival (D) for the SOD-1 (G93A) (n = 17) and ...
<p>(<b>A</b>) Time elapsed until animals lost 15% of their maximum body weight. Mice receiving 1×10<...
<p>A) body weight, B) extension reflex, and C) rotorod test of G93A mice administered with three dif...
<p>(A) IMM was evaluated in Ntg and longitudinally in SOD1<sup>G93A</sup> mice at 12, 14, 17 and 20 ...
<p>(A) Grip strength measurements for the WT (blue) and VCP<sup><b>R155H/+</b></sup> (red) mice plac...
<p>(A) Lateral view of hindlimbs from WT and NF90 Tg mice (line TG1) at 12 weeks of age. An arrow in...
<p><b>A.</b> Myotonia was measured and scored on a 3 point scale with 0 being no myotonia and 3 bein...
<p>Histograms from Kaplan-Meier analysis showing the duration of the early phase (A) and the end sta...
As a model for amyotrophic lateral sclerosis (ALS), transgenic hSOD1(G93A) mice constitute the stand...
<p>(A) Control and MB-treated (3, 10, 30 and 100 mg oral per kg body weight per day) SOD1<sup>G93A</...
Graphs displaying the average longitudinal values of the mdx4cv and control mice muscles in the T2, ...
<p>Group average change from initial body weight (top panels) and neurological disease severity scor...